Adial Pharmaceuticals files initial beneficial ownership statement for CFO Vassiliki Economides

ADIL•2026-10-31

CFO Vassiliki Economides disclosed stock options to buy 307,814 Adial Pharmaceuticals common shares at $5.76 in an initial ownership filing.

1. Options disclosed

Adial Pharmaceuticals Chief Financial Officer Vassiliki Economides disclosed stock options to buy 307,814 common shares at $5.76 in an initial ownership filing.

Sources

Adial Pharmaceuticals files initial beneficial ownership statement for CFO Vassiliki Economides

Sec

Adial Pharmaceuticals files initial beneficial ownership statement for CFO Vassiliki Economides

1. Options disclosed

Related News

LOG Commercial Properties board approves BRL 300 million private commercial note issue

LiveOne interim CFO Craig Christensen to leave effective October 30, 2026

Roivant Sciences president and Immunovant CEO Eric Venker sells $7.32 million in Roivant common shares

Sources

Adial Pharmaceuticals files initial beneficial ownership statement for CFO Vassiliki Economides

Crypto exchanges call for quick moves to bolster defenses after Binance heist

BillionToOne Chairman and CEO Oguzhan Atay reports $1.3 million share sale